Oxford Immunotec to supply T cell testing for UK COVID-19 vaccine trials

By Rachel Arthur contact

- Last updated on GMT

Pic:getty/dusanpetkovic
Pic:getty/dusanpetkovic

Related tags: T cell, COVID-19 vaccine, Uk

Diagnostics company Oxford Immunotec Global PLC has been selected to provide T cell testing to the UK Vaccines Taskforce.

T cells are becoming increasingly recognised for their role in SARS-CoV-2 infection and immunity; measuring the presence and size of any T cell response can give adjunctive information to that available by serology. The UK Vaccines Taskforce therefore is including T cell analysis in COVID-19 vaccine trials.

Oxford Immunotec – which is based in Oxford, UK and Marlborough, Massachusetts - will be the sole supplier of T cell testing for SARS-CoV-2 specific responses in the UK’s COVID-19 vaccine trials.

Its T-SPOT technology has been in operation for 15 years in the field of tuberculosis diagnosis. It will now offer the UK Vaccines Task Force its T-SPOT Discovery​ SARS-CoV-2 assay (research use only): which uses the same technology to allow SARS-CoV-2-specific T cells to be detected and enumerated. 

The award includes the measurement of the magnitude of the SARS-CoV-2 protein-specific T cell response using T-SPOT Discovery​ and is ‘recognition of the company’s ability to deliver clinical grade, consistent and reproducible diagnostic products.’

The UK Government will provide up to £3m ($3.9m) investment for this testing.

Related news

Show more

Related products

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars